Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System
Enzyme Immunoassay, Cocaine And Cocaine Metabolites. 510(k) K213211, from Carolina Liquid Chemistries Corp. (Greensboro, NC). Product code DIO, class 2.
As of Nov 18, 2026, K213211 is an FDA 510(k) held by Carolina Liquid Chemistries Corp., substantially equivalent on Jan 27, 2022 after 120 days, with no recalls tied to it in FDA's recall database.
- Review time: 120 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test System is intended for the qualitative determination of benzoylecgonine (cocaine metabolite) in human urine at a cutoff value of 300 ng/mL. The assay is designed for professional use with a Carolina Liquid Chemistries CLC6410 automated clinical chemistry analyzer. For in vitro diagnostic use only.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Cocaine Metabolite Enzyme Immunoassay Models #0030 (500 Tests Kit), #0031 (5000 Tests Kit)K020763 · Lin-Zhi International, Inc. · May 10, 2002
Other DIO clearances
The newest 510(k)s for the same product code; see every DIO device- DRI Cocaine Metabolite AssayK211973 · Microgenics Corporation · Sep 24, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 29, 2021
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files